Search published articles


Showing 3 results for Mirzaee

M Bonyadi, M Rahimi, M Nahai, M Akbari Dibavar, F Mirzaee,
Volume 4, Issue 2 (Autumn – Winter 2011[PERSIAN] 2010)
Abstract

Abstract

Bachground and objectives:

micro-organisms, usually made from strains of the genera

Probiotics are nonpathogenic and beneficialLactobacillus and

Bifidobacterium. The probiotics are known as dietary supplements withLactobacillus and

Bifidobacterium , in sufficient quantities and specific compound, are used for

Material and Methods:

obtained from dairy products, yogurt, grains cheese, saffron flower, fresh

pinto beans, red beans, fresh green beans . All samples were incubated in

MRS Agar cultures at 42, 37, and 25

isolated, concentrated, and lyophilized. Finally the differential recognition

was performed in deferential cultures.

In this cross-sectional study 100 Samples were°c for two days, and then bacteria were

Results

isolated. Lactobacillus delbrueki and L.bulgaris(each 10 cases)

(8 cases) and L .casei (5 cases) are the most prevalent Lactobacillus strains.

Lactococcus themrophilus the most frequent Lactococcus where isolated in

this study.

: Of 100 food samples 19 Lactobacillus and Lactococcus strains were، L.salivarius

Conclusion:

especially Lactobacillus strains are presented in foods. It is recommended that

these probiotics be isolated and proliferated and used in industry and also for

therapeutic purposes.

Based on the results of this study, many kinds of probiotics

Key words:

probiotic, Lactobacillus, foods

therapeutic purposes and food industry. The aim of this study was to evaluate

the frequency of Lactobacillus and Lactococcus strains in food stuffs cities in

Eastern Azerbaijan, Iran.

beneficial effects on consumer health. In some countries,


Jafarpur M, Nazemi A, Mirzaee A, Rahbar Farzamee Hagh S,
Volume 5, Issue 2 (Autumn – Winter 2011[PERSIAN] 2011)
Abstract

Abstract Background and objectives: Group A Streptococcus (GAS) strains have been identified by serologic methods based on surface protein antigens, T and M. Accordingly, different serotypes have been reported worldwide. Recently, the previous out of date procedures have been replaced by N-terminal emm gene sequence, which has been used in identifying more than 150 emm types. We aimed to determine the prevalence of emm types and phenotypes resistance to erythromycin among streptococci isolated from the throat in north of Iran. Material and Methods: 50 GAS isolates from sore throat of patients referred to a few local hospitals in Tonekabon, Ramsar, and Chalus in northwest of Iran (2010-2011), by using blood agar, bacitracin sensitivity test, PYR test and agglutination by specific antiserum. Antibiotic resistance of the isolates was determined by the discs branded by Iranian Padtan Teb Company, using Kirby Bauer Test, and analyzed by CLSI standards. The mechanism of resistance to erythromycin was evaluated by Double Disk Diffusion Test in the presence of erythromycin and clindamycin. emm gene of all isolates were reproduced and their PCR products sequenced by the Korean Macrogen company. To determine the emm types, using BLAST2.0 program (National Center for Biotechnology Information, available in WWW.ncbi.nlm.nih.gov / BLAST), and the emm gene sequences were compared with sequences in the gene bank. Results: we identified Four different types of emm, including e mm5 (26 52 %), emm12 (12 24%), emm79 (6 % 12) and emm86 (6 % 12). All beta lactam antibiotics have inhibitory effect on isolates, while18% of isolates (9 of 50) are resistant to erythromycin. The most common resistance phenotype is cMLSB (% 66.6) and the next one is phenotype M (% 33.3), but phenotype iMLSB is not observed in none of the isolates. Twelve percent (6cases) of isolates are resistant to clindamycin. Conclusion: The results of present study show different types of GAS than those reported worldwide. The emergences of emm86 in pharyngitis and erythromycin resistance are the two valuable findings of this research. Keywords:Streotococcus pyogenes,erythromycin,cMLSB,iMLSB
Mohammad Ghadami, Leili Shokoohizadeh, Mohsen Mirzaee,
Volume 11, Issue 3 (May-Jun 2017)
Abstract

ABSTRACT
       Background and Objective: Klebsiella pneumoniae is one of the most common causes of bacterial infections. Presence of plasmid-mediated quinolone resistance genes causes low level of resistance in K. pneumoniae. This study investigated the prevalence of resistance to quinolones and fluoroquinolones, and the frequency of qnrA, qnrB and qnrS genes among K. pneumoniae strains.
        Methods: The study was performed on 100 K. pneumoniae strains isolated from hospitals in city of Borujerd (Iran) during April to September 2014. Susceptibility of the isolates to nalidixic acid, ciprofloxacin, norfloxacin and ofloxacin was evaluated. Minimum inhibitory concentration (MIC) of ciprofloxacin was determined using ciprofloxacin Etest strips. Polymerase chain reaction was performed to detect qnrA, qnrB and qnrS genes in quinolone-resistant isolates using specific primers.
      Results: The results showed that 38% of the isolates were resistance to both nalidixic acid and ciprofloxacin. The prevalence of ofloxacin- and norfloxacin-resistant isolates was determined to be 18% and 15%, respectively. The MIC values for ciprofloxacin were ranging from 0.064 to ≥256 μg/ml. In addition, four ciprofloxacin-resistant isolates (10%) had MIC of ≥256 μg/ml. The qnrA gene was not detected in any of the quinolone-resistant isolates. Moreover, 23.6% (n=9) and 5.2% (n=2) of the quinolones-resistant isolates contained the qnrB and qnrS genes, respectively.
      Conclusion: Although 38 isolates were ciprofloxacin-resistant, the qnrB, qnrS genes were detected in a small number of isolates. This indicates the involvement of factors other than the qnr genes in resistance of these isolates to quinolones.
       Keywords: Klebsiella Pneumoniae, Qnr protein, Borujerd.


Page 1 from 1     

© 2007 All Rights Reserved | Medical Laboratory Journal

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.